📰 Chris Schelling News
Chris Schelling News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chris Schelling. Real-time updates on events, politics, business and more.
September 1, 2023
Shares of Acer Therapeutics Inc. (ACER) rose over 98% on Thursday after it entered into a definitive agreement pursuant to which Zevra Therapeutics would acquire it in a merger transaction with a total value of up to $91 million for Acer stockholders.
August 31, 2023
Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics 30-Aug-2023 / 22:20 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solel...
August 31, 2023
Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch30-Aug-2023 / 22:20 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Relief Therapeutics Announces New Exclu...
August 30, 2023
Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch Relief Therapeutics Announces New Exclusive Definitive Lic...
August 30, 2023
Relief Therapeutics Announces New Exclusive Definitive License Agreement ...
August 30, 2023
NEWTON, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and
August 30, 2023
Acer Therapeutics buys Relief Therapeutics' stake in OLPRUVA™ worldwide, excluding geographical Europe, providing an upfront payment of $10 million in cash to Relief Therapeutics with the potential for an
May 15, 2023
U.S. OLPRUVA™ launch progressing ahead of schedule with drug-in-channel now anticipated in mid-June 2023...
May 3, 2023
Seres Therapeutics (NASDAQ:MCRB – Get Rating) and Acer Therapeutics (NASDAQ:ACER – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability. Volatility & Risk Seres Therapeutics has a beta of […]
May 3, 2023
Seres Therapeutics (NASDAQ:MCRB – Get Rating) and Acer Therapeutics (NASDAQ:ACER – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation. Volatility & Risk Seres Therapeutics has a beta of […]